CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,764,416 | +100.9% | 597,324 | +21.7% | 0.00% | +50.0% |
| Q2 2023 | $8,842,955 | +15.4% | 490,730 | +2.8% | 0.00% | 0.0% |
| Q1 2023 | $7,665,245 | -12.9% | 477,288 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $8,798,640 | -6.3% | 480,800 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $9,395,000 | +4.0% | 478,382 | -1.2% | 0.00% | 0.0% |
| Q2 2022 | $9,032,000 | -6.6% | 484,281 | +9.9% | 0.00% | 0.0% |
| Q1 2022 | $9,669,000 | -24.5% | 440,524 | -2.2% | 0.00% | 0.0% |
| Q4 2021 | $12,800,000 | +65.7% | 450,528 | +22.8% | 0.00% | +100.0% |
| Q3 2021 | $7,725,000 | +12.0% | 366,999 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $6,900,000 | +52.9% | 366,114 | +23.9% | 0.00% | 0.0% |
| Q1 2021 | $4,512,000 | +0.7% | 295,393 | -7.0% | 0.00% | 0.0% |
| Q4 2020 | $4,481,000 | -12.2% | 317,536 | -2.5% | 0.00% | 0.0% |
| Q3 2020 | $5,103,000 | +38.8% | 325,681 | +55.1% | 0.00% | 0.0% |
| Q2 2020 | $3,677,000 | +54.0% | 209,930 | +29.3% | 0.00% | 0.0% |
| Q1 2020 | $2,387,000 | -35.9% | 162,345 | +9.4% | 0.00% | 0.0% |
| Q4 2019 | $3,725,000 | +82.5% | 148,442 | +9.4% | 0.00% | – |
| Q3 2019 | $2,041,000 | -24.2% | 135,649 | +25.9% | 0.00% | -100.0% |
| Q2 2019 | $2,694,000 | +13.4% | 107,744 | +3.3% | 0.00% | 0.0% |
| Q1 2019 | $2,375,000 | +3.2% | 104,329 | +36.0% | 0.00% | 0.0% |
| Q4 2018 | $2,301,000 | +5.4% | 76,727 | +0.7% | 0.00% | 0.0% |
| Q3 2018 | $2,184,000 | – | 76,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,126,579 | $33,504,459 | 14.02% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $4,193,340 | 5.38% |
| First Light Asset Management, LLC | 1,583,329 | $47,088,204 | 4.47% |
| Paradigm Biocapital Advisors LP | 2,178,737 | $64,795,638 | 4.40% |
| Bain Capital Life Sciences Investors, LLC | 1,275,552 | $37,934,916 | 4.24% |
| Altium Capital Management LP | 262,000 | $7,791,880 | 4.06% |
| 5AM Venture Management, LLC | 462,286 | $13,748,386 | 3.96% |
| MPM BioImpact LLC | 479,053 | $14,247,036 | 3.80% |
| Affinity Asset Advisors, LLC | 450,000 | $13,383,000 | 3.76% |
| Opaleye Management Inc. | 370,000 | $11,003,800 | 3.58% |